|
|
| Thérapies > Etude de marché sectorielle |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2005 |
Taille du document : |
25 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
MarketWatch: Cancer 33 pages | Mars 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the |
160,00 €
|
| |
| |
Stakeholder Insight: Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer 199 pages | Avril 2005 |
IntroductionAnthracycline-based regimens and tamoxifen are well-established in the treatment of early-stage breast cancer. In recent days, however, agents such as Sanofi-Aventis's Taxotere and Astr |
9 120,00 €
|
| |
| |
The Cancer Market Outlook to 2010 192 pages | Novembre 2005 |
The cancer market has undergone a high degree of innovation led change over the previous five years, which has created strong opportunities for a range of established and emerging biotechnology and ph |
2 443,75 €
|
| |
| |
MarketWatch: Cancer 29 pages | Avril 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the |
160,00 €
|
| |
| |
MarketWatch: Cancer 29 pages | Octobre 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the |
170,00 €
|
| |
| |
Chinese Markets for Cancer Treatment Drugs 218 pages | Septembre 2002 |
China's demand for cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's e |
2 835,00 €
|
| |
| |
MarketWatch: Cancer 32 pages | Juillet 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the |
160,00 €
|
| |
| |
Commercial Insight: Antihormonal Therapies Aromatase Inhibitors Reinvigorate a Mature Market 122 pages | Juillet 2005 |
IntroductionThe antihormonal cancer therapy market is characterized by a mature nature and a relatively high level of saturation. Despite this, growth will continue slowly at a CAGR of 0.9% during |
12 160,00 €
|
| |
| |
MarketWatch: CNS 27 pages | Mai 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analys |
160,00 €
|
| |
| |
MarketWatch: Cancer 30 pages | Juin 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the |
160,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the   CNS industry.
|
|
In this month’s MarketWatch…  
 
  This month's highlights   Page 2 - Key Announcements   Page 2 - CNS News Round-Up  
  Neurology   Page 4 - Opinion: Schwarz: lacosamide on track for dual approval…   Page 5 - Headlines   Page 5 - Alzheimer's Disease Update   Page 6 - Multiple Sclerosis Update   Page 7 - Parkinson's Disease Update  
  Psychiatry   Page 9 - Headlines   Page 9 - Depression Update   Page 11 - Behavioral Disorders Update  
  Pain   Page 13 - Headlines   Page 13 - R&D Update   Page 15 - Regulatory Update   Page 16 - Licensing & Collaborations Update  
  Company Spotlight   Page 18 - Forest Laboratories  
  Further Reading   Page 23  
 
  Index   Page 24 - Pharma companies   Page 24 - Biotech companies   Page 25 - Key Drugs  
|
|
|
PPLSEN
|
|
|
|
|